Jan Vishwas Bill: The Jan Vishwas (Amendment of Provisions) Bill, 2026 amends 784 provisions across 79 central Acts overseen by 23 ministries. Of these, 717 provisions are decriminalised under an “ease of doing business” framework, and 67 target “ease of living”.
Five health laws are central to the reform: the Drugs and Cosmetics Act, 1940, Pharmacy Act, 1948, Food Safety and Standards Act, 2006, Clinical Establishments Act, 2010, and the National Commission for Allied and Healthcare Professions Act, 2021. Across these laws, imprisonment for minor violations is replaced with monetary penalties and administrative adjudication.
READ | Ease of doing business reforms face regulatory test
The shift is clear: criminal liability is no longer the default enforcement tool for routine compliance failures.
Decriminalisation of health laws
Under the Drugs and Cosmetics Act, procedural violations—such as failure to maintain records or furnish information—move out of the criminal court system. Adjudicating authorities, appointed by central and state governments, will impose penalties through structured processes: show-cause notices, hearings, and appeals.
The Pharmacy Act and Food Safety Act follow the same direction: higher financial penalties, simplified enforcement, and proportionality. The Clinical Establishments Act shifts non-critical deficiencies to civil penalties. The Allied Healthcare Professions Act strengthens compliance through graded sanctions.
The design is consistent across laws. Minor violations are monetised. Serious violations remain criminal, at least in principle.
From courts to administrators
India’s health regulation has relied on criminal liability, often for procedural lapses. The result was predictable: litigation, delay, and uneven enforcement. Small providers—clinics, pharmacies, labs—bore the brunt.
The Bill replaces this with administrative enforcement. Adjudicating officers become the primary decision-makers. Compliance shifts from courts to bureaucracy. This reduces litigation. It also redistributes power.
READ | Deregulation commission: Will less government mean higher growth?
Compliance relief for small providers
Minor errors in licensing, reporting, or record-keeping no longer trigger criminal proceedings. For small providers, this removes a disproportionate risk.
In rural and underserved areas, where compliance capacity is thin, the shift matters. Providers can continue operations without the threat of prosecution for procedural lapses. The reform lowers entry barriers. It may also bring informal providers into the regulatory system.
Standardisation and predictability
The Bill introduces structured penalty processes across laws. Show-cause notices, hearings, and appeals are now embedded. This reduces inspector discretion, at least on paper. Enforcement becomes more rule-bound. Predictability improves.
The alignment across 23 ministries signals an attempt to harmonise regulatory practice, not just amend statutes.
Global convergence, Indian constraints
Graduated civil penalties are standard in advanced regulatory systems. Criminal sanctions are typically reserved for fraud, gross negligence, or harm.
The Bill aligns India with this model. But institutional capacity is the constraint. Administrative enforcement requires trained adjudicators, credible processes, and independence. These are uneven in India.
Deterrence: where the line sits
The reform hinges on one boundary: what counts as “minor”.
If this boundary shifts in practice—towards classifying violations as procedural to avoid prosecution—the deterrent effect weakens. This is not theoretical. Enforcement in India has historically been discretionary. The Bill leaves this boundary largely to rules, not statute.
The success of the reform depends on adjudicating officers. Their competence, independence, and resourcing are critical. India’s regulatory agencies are capacity-constrained. Without investment, shifting enforcement from courts to administrators does not strengthen regulation. It relocates it.
Fines as cost of doing business
Monetary penalties introduce a predictable risk. For large hospitals and pharmaceutical firms, this risk is absorbable. Fines can be priced in. For small providers, the same penalties are binding constraints. Without differentiated penalty design, enforcement becomes regressive.
A softer enforcement regime reduces the incentive to disclose violations. This matters in areas where monitoring is already weak: drug quality, adverse events, hospital infections.
Criminal liability, though rarely invoked, acted as a backstop. Its removal changes behaviour at the margin.
Patient rights: largely implicit
The Bill is framed around regulated entities. Patient and consumer rights are not central to its design.
Criminal liability has been one of the few avenues for redress in cases of negligence. Diluting it without strengthening alternative mechanisms—ombudsman systems, compensation frameworks—creates gaps.
Ease of business versus public health
The Bill treats regulation as a compliance burden to be eased. A public health framework treats regulation as a protective instrument.
This distinction matters. In a system with weak surveillance, under-regulation of pharmaceuticals, and limited oversight of private care, enforcement is not merely procedural. It is structural.
Governance concerns: discretion without statute
Key enforcement boundaries—classification of violations, escalation thresholds—are left to executive rule-making.
This expands discretion. It reduces parliamentary oversight over core elements of criminal liability reform.
Adjudication powers are vested in executive officers, including District Magistrates. Judicial oversight is reduced.
The risk is not just inconsistency. It is politicisation and rent-seeking.
Civil society: uneven counterweight
India’s health rights movement—particularly the Jan Swasthya Abhiyan—has demonstrated capacity for legislative engagement. Its 2024 convention and policy submissions show organisational depth.
At the state level, organisations like SATHI have built local accountability mechanisms. These are partial correctives. They cannot substitute for statutory safeguards.
READ | Skilling India: Why Apprenticeship Act overhaul falls short
Kerala’s lesson: proximity weakens oversight
The experience of Kerala Sastra Sahitya Parishad is instructive. It combined activism with policy partnership during the People’s Planning Campaign.
Over time, proximity to the state diluted adversarial oversight. Expert dominance widened the gap with communities—Dalits, Adivasis, migrants.
Civil society that is embedded in governance struggles to hold it accountable.
Jan Vishwas Bill: Structural limits of the health rights
Health rights advocacy in India is fragmented. Legal capacity is limited. Industry lobbies are better organised.
Even where legislation exists—such as the Rajasthan Right to Health Care Act—implementation faces pushback from private providers. Sustained engagement, not episodic mobilisation, is required.
The Bill shifts India’s regulatory model from punitive to administrative. It reduces compliance costs and litigation. It also introduces new risks: weaker deterrence, greater discretion, uneven enforcement, and gaps in patient protection.
The outcome depends on three variables: adjudication quality, clarity of enforcement boundaries, and parallel strengthening of surveillance and redress systems. Without these, decriminalisation risks becoming deregulation.